Dr Adi Idris from the School of Biomedical Sciences, QUT, discusses how RNA biologics are now emerging as realistic and achievable clinically translatable treatment modalities for a range of human diseases. Importantly, respiratory viruses are amenable to gene therapy-based targeting.
